Lightnews — Scholar-powered news

Stockoscope @stockoscope.bsky.social · 1d

Sharing results of DCF analysis on #AMAT from our platform (Oct 10, 2025)...

Current: $220.30
Intrinsic Value: $174.77
The stock appears 20.7% overvalued

Full breakdown below 👇
youtu.be/GwZimtU37Ns?...

Found this helpful?

👉Like | Share | Follow for more.

#Finance #StockMarket #Valuation

AMAT DCF Analysis: 21% Overvalued at $220.30

YouTube video by Stockoscope

youtu.be

Stockoscope @stockoscope.bsky.social · 1d

7/7 Want to run your own DCF analysis?

Analyze any S&P 500 stock at https://stockoscope.com

◆ Transparent methodology
◆ Full calculation breakdown
◆ Adjust assumptions

Found this helpful?

Like | Share | Follow for more

Educational only. Not investment advice.

Stockoscope @stockoscope.bsky.social · 1d

6/7 Sensitivity Analysis

Are the 8.8% growth assumptions realistic? Is 3.5% terminal growth too optimistic?
Share your thoughts below 👇

Want to test different scenarios? Adjust any input parameters on our platform and see how valuation changes with your assumptions.

1

Stockoscope @stockoscope.bsky.social · 1d

5/7 Valuation Results

Enterprise Value: $144.3B
Less: Net Debt
Equals: Equity Value $145.8B

Terminal Value: ~59% of total value

Present value of all future cash flows discounted at 9.8% WACC.

1

Stockoscope @stockoscope.bsky.social · 1d

4/7 Cash Flow Projections

Years 1-5: High-Growth Period (8.8% initial)
Years 6-10: Tapering Period
Year 11+: Terminal Growth (3.5%)
Source: model-derived estimates projections

Exponential tapering prevents unrealistic perpetual high growth assumptions.

1

Stockoscope @stockoscope.bsky.social · 1d

3/7 Risk Assessment (WACC: 9.8%)

Capital Structure:
- Equity: 99.7%
- Debt: 0.4%

Beta: 1.48

WACC reflects company-specific risk profile using Damodaran methodology and current market data.

1 1

Stockoscope @stockoscope.bsky.social · 1d

2/7 Growth Analysis & DCF Methodology

Two-phase growth modeling:
Phase 1 Growth: 8.8% (5 years)
Tapering: 5 years to 3.5% terminal
Source: model-derived estimates

Using institutional-grade weighted regression analysis and exponential tapering.

1

Stockoscope @stockoscope.bsky.social · 1d

🧵 1/7 AMAT DCF Analysis Thread

Sharing results of DCF analysis on $AMAT from our platform (Oct 10, 2025)...

Current: $220.30
Intrinsic Value: $174.77
The stock appears 20.7% overvalued

Full breakdown below 👇

#AMAT #DCF #Valuation

1

Stockoscope @stockoscope.bsky.social · 1d

7/7 Want to run your own DCF analysis?

Analyze any S&P 500 stock at https://stockoscope.com

◆ Transparent methodology
◆ Full calculation breakdown
◆ Adjust assumptions

Found this helpful?

Like | Share | Follow for more

Educational only. Not investment advice.

Stockoscope @stockoscope.bsky.social · 1d

6/7 Sensitivity Analysis

Are the 12.9% growth assumptions realistic? Is 4.0% terminal growth too optimistic?
Share your thoughts below 👇

Want to test different scenarios? Adjust any input parameters on our platform and see how valuation changes with your assumptions.

Sensitivity analysis interface showing adjustable DCF parameters including growth rates, discount rate, and forecast period

1

Stockoscope @stockoscope.bsky.social · 1d

5/7 Valuation Results

Enterprise Value: $230.8B
Less: Net Debt
Equals: Equity Value $232.3B

Terminal Value: ~68% of total value

Present value of all future cash flows discounted at 8.8% WACC.

Enterprise value to equity value bridge showing present value of cash flows, terminal value, net debt adjustment, and per-share valuation

1

Stockoscope @stockoscope.bsky.social · 1d

4/7 Cash Flow Projections

Years 1-5: High-Growth Period (12.9% initial)
Years 6-10: Tapering Period
Year 11+: Terminal Growth (4.0%)
Source: model-derived estimates projections

Exponential tapering prevents unrealistic perpetual high growth assumptions.

Multi-year DCF cash flow projection table showing revenue, growth rates, free cash flow, and present values

1

Stockoscope @stockoscope.bsky.social · 1d

3/7 Risk Assessment (WACC: 8.8%)

Capital Structure:
- Equity: 99.6%
- Debt: 0.4%

Beta: 1.23

WACC reflects company-specific risk profile using Damodaran methodology and current market data.

Weighted Average Cost of Capital (WACC) breakdown showing capital structure, cost of equity components, and cost of debt calculation

1 1

Stockoscope @stockoscope.bsky.social · 1d

2/7 Growth Analysis & DCF Methodology

Two-phase growth modeling:
Phase 1 Growth: 12.9% (5 years)
Tapering: 5 years to 4.0% terminal
Source: model-derived estimates

Using institutional-grade weighted regression analysis and exponential tapering.

DCF model assumptions showing initial growth rate, terminal growth rate, forecast period, and EBITDA margin

1

Stockoscope @stockoscope.bsky.social · 1d

🧵 1/7 ADBE DCF Analysis Thread

Sharing results of DCF analysis on $ADBE from our platform (Oct 9, 2025)...

Current: $348.77
Intrinsic Value: $516.24
The stock appears significantly undervalued (48.0%)

Full breakdown below 👇

#ADBE #DCF #Valuation

Chart comparing current stock price to DCF intrinsic value estimate with valuation gap analysis

1

Stockoscope @stockoscope.bsky.social · 1d

5/7 Valuation Results

Enterprise Value: $76.4B
Less: Net Debt
Equals: Equity Value $71.6B

Terminal Value: ~70% of total value

Present value of all future cash flows discounted at 8.0% WACC.

Stockoscope @stockoscope.bsky.social · 1d

4/7 Cash Flow Projections

Years 1-5: High-Growth Period (6.8% initial)
Years 6-10: Tapering Period
Year 11+: Terminal Growth (4.0%)
Source: model-derived estimates projections

Exponential tapering prevents unrealistic perpetual high growth assumptions.

1 1

Stockoscope @stockoscope.bsky.social · 1d

3/7 Risk Assessment (WACC: 8.0%)

Capital Structure:
- Equity: 98.6%
- Debt: 1.4%

Beta: 1.05

WACC reflects company-specific risk profile using Damodaran methodology and current market data.

1

Stockoscope @stockoscope.bsky.social · 1d

2/7 Growth Analysis & DCF Methodology

Two-phase growth modeling:
Phase 1 Growth: 6.8% (5 years)
Tapering: 5 years to 4.0% terminal
Source: model-derived estimates

Using institutional-grade weighted regression analysis and exponential tapering.

1 1

Stockoscope @stockoscope.bsky.social · 1d

7/7 Want to run your own DCF analysis?

Analyze any S&P 500 stock at https://stockoscope.com

◆ Transparent methodology
◆ Full calculation breakdown
◆ Adjust assumptions

Found this helpful?

Like | Share | Follow for more

Educational only. Not investment advice.

Stockoscope @stockoscope.bsky.social · 1d

6/7 Sensitivity Analysis

Are the 6.2% growth assumptions realistic? Is 4.0% terminal growth too optimistic?
Share your thoughts below 👇

Want to test different scenarios? Adjust any input parameters on our platform and see how valuation changes with your assumptions.

1

Stockoscope @stockoscope.bsky.social · 1d

5/7 Valuation Results

Enterprise Value: $2.9T
Less: Net Debt
Equals: Equity Value $2.8T

Terminal Value: ~72% of total value

Present value of all future cash flows discounted at 7.7% WACC.

1

Stockoscope @stockoscope.bsky.social · 1d

4/7 Cash Flow Projections

Years 1-5: High-Growth Period (6.2% initial)
Years 6-10: Tapering Period
Year 11+: Terminal Growth (4.0%)
Source: model-derived estimates projections

Exponential tapering prevents unrealistic perpetual high growth assumptions.

1

Stockoscope @stockoscope.bsky.social · 1d

3/7 Risk Assessment (WACC: 7.7%)

Capital Structure:
- Equity: 98.0%
- Debt: 2.1%

Beta: 0.98

WACC reflects company-specific risk profile using Damodaran methodology and current market data.

1

Stockoscope @stockoscope.bsky.social · 1d

2/7 Growth Analysis & DCF Methodology

Two-phase growth modeling:
Phase 1 Growth: 6.2% (5 years)
Tapering: 5 years to 4.0% terminal
Source: model-derived estimates

Using institutional-grade weighted regression analysis and exponential tapering.

1